Drug Database
Back to search

United Kingdom· GB-APID-3900111000001104

Synacthen Depot 1mg/1ml suspension for injection ampoules

A tetracosactide product containing tetracosactide, registered in United Kingdom by Atnahs Pharma UK Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC H01AA02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedSynacthen Depot 1mg/1ml suspension fo…ATCH01AA02REGISTER NO.GB-APID-3900111000001…PACKS LISTED5CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tetracosactideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tetracosactide is registered in 10 of 19 countries.

Countries holding a registration under ATC H01AA02 (tetracosactide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose
Search tetracosactide products by name

Tetracosactide · ATC H01AA02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tetracosactide
Manufacturer
Atnahs Pharma UK Ltd
Country
United Kingdom (GB)
ATC code
H01AA02
ATC class
Tetracosactide
Defined daily dose
0.25 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 5

  • gtin
    5036631851945
  • gtin
    5391525930077
  • gtin
    5391525930183
  • gtin
    5391525930176
  • gtin
    05056227203743

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

295 interactions on record for tetracosactide.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tetracosactide against other medicinesHow interaction checks work

Tetracosactide · interactions on record

295 records

  • 29 severe
  • 246 moderate
  • 20 minor

Most severe, free to view

  • DesirudinB01AE01severe
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Liquid paraffinA06AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetracosactide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetracosactide products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Synacthen Ampulle, Synacthen Depot
  • Belgium · Synacthen, Synacthen Depot
  • Denmark · Synacthen
  • France · Synacthene, Synacthene Retard
  • Ireland · Synacthen
  • Italy · Synacthen
  • Luxembourg · Synacthen, Synacthen Dépôt
  • Netherlands · Synacthen
  • Sweden · Synacthen, Synacthen Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd8f0cef-9622-4964-b6b3-7a32782f66a0
GET /v1/drugs/dd8f0cef-9622-4964-b6b3-7a32782f66a0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3900111000001104",
  "desc": "Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd)",
  "form": "Suspension for injection",
  "vpid": "3909111000001109",
  "source": "dmd",
  "vtm_id": "777729008",
  "strength": "1 mg",
  "substance": "Tetracosactide",
  "ingredient": "Tetracosactide acetate",
  "supplier_code": "28790911000001109"
}
API referenceMCP serverPlans

See everything about tetracosactide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console